Phase II single arm trial of aflibercept in patients with recurrent temozolomide-resistant glioblastoma: NABTC 0601 Meeting Abstract
| Authors: | De Groot, J. F.; Wen, P. Y.; Lamborn, K.; Chang, S.; Cloughesy, T. F.; Chen, A. P.; DeAngelis, L. M.; Mehta, M. P.; Gilbert, M. R.; Yung, W. K.; Prados, M. D. |
| Abstract Title: | Phase II single arm trial of aflibercept in patients with recurrent temozolomide-resistant glioblastoma: NABTC 0601 |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 94s |
| Language: | English |
| ACCESSION: | WOS:000208457400518 |
| DOI: | 10.1200/jco.2008.26.15_suppl.2020 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2020 -- Source: Wos |
